Attention Deficit Hyperactivity Disorder ADHD is one of the most prevalent paediatric neurodevelopmental diseases. It is most commonly diagnosed in childhood and lasts far into adulthood. Children with ADHD may struggle to pay attention, manage impulsive actions (doing without considering the consequences), or be extremely active.
Despite all the advantages, contraindications and side-effects associated with ADHD drugs are hampering the quality of life of patients, which is expected to hamper revenue growth of the attention deficit hyperactivity disorder therapeutics market over the forecast period.
Attention Deficit Hyperactivity Disorder drugs are associated with contraindications such as allergic reactions to molecules or other medicines, as well as medical conditions such as coronary artery disease, bipolar disorder, blood vessel problems, hypertension, kidney disease, seizures, pancytopenia, mydriasis, thrombocytopenic purpura, and visual disturbances.
Attention Deficit Hyperactivity Disorder medications have been linked to side effects such as hallucinations, rapid or irregular heartbeat, severe nausea or vomiting, seizure, impotence, numbness, burning, or tingling, decreased appetite, severe headache, upper abdomen and stomach discomfort, and weight loss. A significant number of contraindications and adverse effects associated with ADHD medications are restricting prescriptions depending on a patient's medical condition, which is predicted to slow revenue development.
Due to their sensitivity to the pandemic's discomfort and physical distancing measures, the COVID-19 pandemic is unquestionably a tough period for those with attention deficit hyperactivity disorder. Individuals with ADHD may experience more behavioural issues as a result of these measures. ADHD therapies will see a large increase in sales as a result of this.
Read more @ https://cmiaspireblog.blogspot.com/2021/12/attention-deficit-hyperactivity.html
